遗传因素对非洲黑人患者华法林剂量的影响:系统综述与荟萃分析
该系统综述与荟萃分析纳入48项研究共2336例患者,评估遗传因素对非洲黑人华法林稳定剂量的影响。CYP2C9变异(*2、*3、*5、*6、*11)和VKORC1多个变异均与剂量降低相关,rs7294则与剂量增加相关,rs12777823亦与剂量降低相关。非洲本土研究较少且样本量小,需进一步研究。
要点
- CYP2C9*2、*3、*5、*6、*11分别使华法林周剂量降低6.8、12.5、13.4、8.1、5.3 mg。
- VKORC1 rs9923231等5个变异使周剂量降低11.7–21.6 mg,rs7294使周剂量增加6.9 mg。
- rs12777823与周剂量降低12.7 mg相关,非洲黑人数据仍有限。
核心结论
- CYP2C9多个变异、VKORC1多个变异及rs12777823与非洲黑人华法林稳定剂量降低相关,VKORC1 rs7294与剂量增加相关。
研究设计与样本
- 系统综述与荟萃分析,纳入48项研究、共2336例患者,评估遗传因素对非洲黑人华法林剂量的影响。
主要发现
- CYP2C9 rs1799853(*2)、rs1057910(*3)、rs28371686(*5)、rs9332131(*6)、rs28371685(*11)分别使华法林周剂量降低6.8、12.5、13.4、8.1、5.3 mg。
- VKORC1 rs9923231(-1639G>A)、rs9934438(1173C>T)、rs2359612(2255C>T)、rs8050894(1542G>C)、rs2884737(497T>G)分别使周剂量降低18.1、21.6、17.3、11.7、19.6 mg。
- VKORC1 rs7294(3730G>A)使周剂量增加6.9 mg。
- rs12777823(CYP2C基因簇)与周剂量降低12.7 mg相关。
临床怎么用
- 在非洲黑人患者中启动华法林时,可关注CYP2C9*2、*3、*5、*6、*11及VKORC1 rs9923231等变异以辅助预估较低剂量需求。
- VKORC1 rs7294与剂量增加相关,rs12777823与剂量降低相关,解读时应结合具体变异方向。
局限性
- 非洲本土开展的研究较少,患者数量小,需在非洲黑人中进一步研究以评估决定华法林反应的遗传因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Warfarin is the most commonly used oral anticoagulant in sub-Saharan Africa. Dosing is challenging due to a narrow therapeutic index and high interindividual variability in dose requirements. To evaluate the genetic factors affecting warfarin dosing in black-Africans, we performed a meta-analysis of 48 studies (2,336 patients). Significant predictors for CYP2C9 and stable dose included rs1799853 (CYP2C9*2), rs1057910 (CYP2C9*3), rs28371686 (CYP2C9*5), rs9332131 (CYP2C9*6), and rs28371685 (CYP2C9*11) reducing dose by 6.8, 12.5, 13.4, 8.1, and 5.3 mg/week, respectively. VKORC1 variants rs9923231 (-1639G>A), rs9934438 (1173C>T), rs2359612 (2255C>T), rs8050894 (1542G>C), and rs2884737 (497T>G) decreased dose by 18.1, 21.6, 17.3, 11.7, and 19.6 mg/week, respectively, whereas rs7294 (3730G>A) increased dose by 6.9 mg/week. Finally, rs12777823 (CYP2C gene cluster) was associated with a dose reduction of 12.7 mg/week. Few studies were conducted in Africa, and patient numbers were small, highlighting the need for further work in black-Africans to evaluate genetic factors determining warfarin response.
引用
- Asiimwe IG, Zhang EJ, Osanlou R, et al. Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis. Clin Pharmacol Ther. 2020. PMID: 31869433. doi:10.1002/cpt.1755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。